MarketsandMarkets: Global Next Generation Sequencing (NGS) Market Worth $2,343 Million by 2016
DALLAS, April 2, 2012 /PRNewswire/ --
The "Next Generation Sequencing (NGS) Market by Technology (Pyrosequencing & Others), Competitors (Illumina, 454 Roche, Life Science Technologies), Applications and Tools - Global Trends and Forecasts (2011-2016)" analyzes and studies the major market drivers, restraints, and opportunities in regions such as North America, Europe, Asia and Rest of the world.
Browse market data tables and in-depth TOC on "Next Generation Sequencing (NGS) Market by Technology (Pyrosequencing & Others), Competitors (Illumina, 454 Roche, Life Science Technologies), Applications and Tools - Global Trends and Forecasts (2011-2016)".
Early buyers will receive 10% customization on reports.
Next generation sequencing is the next generation of DNA sequencing which includes several technologies to determine the order of nucleotide bases in a molecule of DNA. It is the fastest growing and the most lucrative segment in the genomics space. With estimated double digit growth, next generation sequencing will revolutionize the medical research in academic laboratories, biopharma, and the applied markets.
Major applications include whole genome sequencing, exome sequencing, targeted re-sequencing, transcriptome sequencing, RNA sequencing, and ChipSEQ. Emerging platforms in this market would be those focusing on nanopore technologies.
The major factors driving the NGS Market [ http://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.html ] is the decrease in the cost of sequencing with increase in the number of applications of sequencing in various fields of science such as cancer research, bio-fuels, marine sciences, live stock research, agricultural, and veterinary research. Thus, there is more demand for the equipment to understand the genome sequencing and utilize it further for human and environmental benefits.
The global NGS market was valued at $842.5 million in the year 2011, growing at a CAGR of 22.7% from 2012 to 2016. North America commanded the largest share of 51.8% of the overall NGS technology market in 2011.
The Next Generation Sequencing Market is dynamic and innovative; it is also paving its ways into the labs which were previously not involved in sequencing. High pace of NGS research is likely to boost the market for personal genome sequencing in the coming years. Manufacturers predominantly have an inclination towards diagnostic applications both as a supplier and manufacturer. Key players in this market include Illumina (U.S.), Life Technologies (U.S.), 454 Roche (Switzerland), Oxford Nanopore Technologies (U.K.), and Pacific Biosciences (U.S.).
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology [ http://www.marketsandmarkets.com/biotech-market-research-5.html ], chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com.
17304 Preston Road,
Suite 800, Dallas North - Dominion Plaza, TX 75252
MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/
SOURCE MarketsandMarketsBack to top